What role Fab-glycan plays in the functionality of ACPA-IgGs is unknown so far, but studies have shown that ACPA-IgG in RA have a pro-inflammatory Fc glycosylation pattern with reduced galactosylation and sialylation levels (177, 178). The gene discussed is PRTN3; the disease is rheumatoid arthritis.